Partial Versus Complete Bacillus Calmette-Guérin Intravesical Therapy and Bladder Cancer Outcomes in High-risk Non–muscle-invasive Bladder Cancer: Is NIMBUS the Full Story?

BACKGROUND: It is important to understand the implications of reduced bacillus Calmette-Guérin (BCG) treatment intensity, given global shortages and early termination of the NIMBUS trial. OBJECTIVE: To assess the association of partial versus complete BCG induction with outcomes. DESIGN, SETTING, AN...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezaee, Michael E., Ismail, A. Aziz Ould, Okorie, Chiamaka L., Seigne, John D., Lynch, Kristine E., Schroeck, Florian R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Bladder Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317819/
https://www.ncbi.nlm.nih.gov/pubmed/34337506
http://dx.doi.org/10.1016/j.euros.2021.01.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317819/
https://www.ncbi.nlm.nih.gov/pubmed/34337506
http://dx.doi.org/10.1016/j.euros.2021.01.009

Ejemplares similares